Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Cameron John ReynoldsPresident and CEO | VolitionrxVNRX | Open-market buy | 25/11/17 | 25/11/17 | 20,000 sh | $0.35 | $7,000 | +0.8% |
Timothy I. StillDirector | VolitionrxVNRX | Open-market buy | 25/10/14 | 25/10/15 | 48,076 sh | $0.51 | $24,518.76 | +3.2% |
Cameron John ReynoldsPresident and CEO | VolitionrxVNRX | Open-market buy | 25/10/14 | 25/10/15 | 110,000 sh | $0.51 | $56,100 | +4.5% |
Guy Archibald InnesDirector | VolitionrxVNRX | Open-market buy | 25/10/14 | 25/10/15 | 96,153 sh | $0.51 | $49,038.03 | +9.9% |
Cameron John ReynoldsPresident and CEO | VolitionrxVNRX | Open-market buy | 25/09/12 | 25/09/15 | 15,000 sh | $0.66 | $9,900 | +0.6% |
Cameron John ReynoldsPresident and CEO | VolitionrxVNRX | Open-market buy | 25/08/05 | 25/08/06 | 78,125 sh | $0.64 | $50,000 | +3.1% |
Guy Archibald InnesDirector | VolitionrxVNRX | Open-market buy | 25/08/05 | 25/08/06 | 78,125 sh | $0.64 | $50,000 | +8.8% |
Cameron John ReynoldsPresident and CEO | VolitionrxVNRX | Open-market buy | 25/06/12 | 25/06/16 | 12,500 sh | $0.59 | $7,375 | +0.5% |
Guy Archibald InnesDirector | VolitionrxVNRX | Open-market buy | 25/06/03 | 25/06/04 | 20,000 sh | $0.54 | $10,800 | +2.3% |
Cameron John ReynoldsPresident and CEO | VolitionrxVNRX | Open-market buy | 25/05/19 | 25/05/19 | 20,000 sh | $0.44 | $8,800 | +0.9% |
Jacob Vincent MicallefChief Scientific Officer | VolitionrxVNRX | Open-market buy | 25/05/19 | 25/05/19 | 50,000 sh | $0.43 | $21,500 | +13.3% |
Cameron John ReynoldsPresident and CEO | VolitionrxVNRX | Open-market buy | 25/03/26 | 25/03/27 | 181,818 sh | $0.55 | $99,999.9 | +8.6% |
Guy Archibald InnesDirector | VolitionrxVNRX | Open-market buy | 25/03/26 | 25/03/27 | 181,818 sh | $0.55 | $99,999.9 | +26.5% |
Timothy I. StillDirector | VolitionrxVNRX | Open-market buy | 24/12/09 | 24/12/10 | 87,382 sh | $0.57 | $49,807.74 | +6.2% |
Cameron John ReynoldsPresident and CEO | VolitionrxVNRX | Open-market buy | 24/12/09 | 24/12/10 | 139,811 sh | $0.57 | $79,692.27 | +7.1% |
Guy Archibald InnesDirector | VolitionrxVNRX | Open-market buy | 24/12/09 | 24/12/10 | 174,764 sh | $0.57 | $99,615.48 | +39.5% |
Jacob Vincent MicallefChief Scientific Officer | VolitionrxVNRX | Open-market buy | 24/12/09 | 24/12/10 | 43,691 sh | $0.57 | $24,903.87 | +12.5% |
Guy Archibald InnesDirector | VolitionrxVNRX | Open-market buy | 24/08/20 | 24/08/21 | 150,000 sh | $0.67 | $100,500 | +58.4% |
Hever Investments10% Owner | VolitionrxVNRX | Open-market sale | 24/01/02 | 24/01/03 | 20,000 sh | $0.90 | $18,000 | −6.3% |
Eight10% Owner | VolitionrxVNRX | Open-market sale | 24/01/02 | 24/01/03 | 20,000 sh | $0.90 | $18,000 | −6.3% |